Results 221 to 230 of about 4,914,110 (289)
Acta Physiologica, Volume 242, Issue 9, September 2026.ABSTRACT In the central nervous system (CNS), the tissue microenvironment is continuously monitored and regulated to secure the unobstructed function of neurons and of their networks. This is a key function of the neurovascular niche (NVN), which is the interface between the cells of the nervous tissue and the cells and the content of blood vessels. It
Ilias Kazanis +4 more
wiley +1 more source
British Journal of Haematology, Volume 209, Issue 3, Page 1031-1038, September 2026.In this 28‐patient retrospective cohort, rituximab‐based regimens for IgM‐related neuropathy yielded significant, sustained functional and neurological improvements over a 2‐year follow‐up. Furthermore, reductions in serum IgM levels correlated with improved Inflammatory Neuropathy Cause and Treatment disability scores, highlighting the long‐term ...
Maria Gavriatopoulou +15 more
wiley +1 more source
Clinical Genetics, Volume 110, Issue 3, Page 363-368, September 2026.FIG4 is essential for lysosomal homeostasis. FIG4‐related disorders present as a continuous spectrum from the juvenile lethality in Yunis‐Varon syndrome to an increased risk of amyotrophic lateral sclerosis (ALS) in adult life. FIG4‐related disorders comprise a novel group of disorders of lysosomal homeostasis and can be classified into severe ...
Pankaj Prasun, Matthew Rasberry
wiley +1 more source
Developmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1269-1280, September 2026.Unilateral cerebral palsy (CP) affects 826 children in the Canadian CP Registry: 69% born at term, 15% 32 to 37 weeks, and 16% less than 32 weeks. Gestational age at birth did not affect impairments such as vision or hearing impairment, ambulation, seizures, or feeding difficulty.
Johanie Victoria Piché +6 more
wiley +1 more source
Consensus‐based follow‐up and treatment registry for GNAO1‐associated disorder
Developmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1316-1324, September 2026.This original article is commented on by Domínguez‐Carral and Ortigoza‐Escobar on pages 1182–1183 of this issue. Abstract Aim To establish consensus‐based recommendations on relevant domains of functioning and assessment instruments for an GNAO1‐associated disorder follow‐up and treatment registry.
Larissa R. Heideman +9 more
wiley +1 more source
Developmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1195-1206, September 2026.This scoping review highlights that collaboration between healthcare and physical activity providers to support community physical activity participation for young people with childhood‐onset physical disability is limited. Collaboration strategies to support community physical activity lack sufficient detail for replication.
Karen Brady +5 more
wiley +1 more source
Optic neuritis due to demyelinating disease
Indian Journal of Ophthalmology, 1975 Sood G +5 more
doaj
Muscle &Nerve, Volume 74, Issue 3, Page 761-762, September 2026.
Antoine Pegat +2 more
wiley +1 more source
European Journal of Neurology, Volume 33, Issue 9, September 2026.ABSTRACT Background The therapeutic landscape of generalised myasthenia gravis (gMG) has evolved substantially with the approval of targeted immunotherapies, including complement C5 inhibitors (C5‐I) and neonatal Fc receptor inhibitors (FcRn‐I). While pivotal trials have demonstrated marked efficacy in defined subgroups, real‐world experience reveals ...
Andreas Meisel +17 more
wiley +1 more source
The Emerging Role of UCHL1 in Neurological and Musculoskeletal Diseases
Immunology &Cell Biology, Volume 104, Issue 8, Page 783-793, September 2026.UCHL1‐associated pathology. The pathological role of UCHL1 in multisystem diseases, including cancer, neurological, musculoskeletal and cardiovascular disorders. ABSTRACT Ubiquitin C‐terminal hydrolase L1 (UCHL1) is a highly conserved deubiquitinating enzyme that has transitioned from being viewed as a “brain‐specific” protein to a global regulator of ...
Ru Feng +3 more
wiley +1 more source